SidneyMallenbaumMDFAHA, FAANEM

Neurology • Pensacola, FL

Neuromuscular Medicine, Vascular Neurology

Associate Professor, Internal Medicine, Division of Neurology, Virginia Tech Carilion School of Medicine Medical Director, Primary Stroke Center, Carilion Medical Center, Roanoke, VA

Join to view full profile

Dr. Mallenbaum is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Mallenbaum's full profile

Already have an account?

Office
790 Veterans Way
India Section, Neurology Division
Pensacola, FL 32507
Phone+1 850-912-2000

Summary

Dr. Sidney Mallenbaum is a neurologist in Pensacola, FL. He received his medical degree from University of North Carolina at Chapel Hill School of Medicine and has been in practice 37 years. He specializes in neuromuscular medicine and electrodiagnostic medicine.

Education & Training

University of North Carolina at Chapel Hill School of MedicineClass of 1986

Certifications & Licensure

VA State Medical License 1990 - 2026
FL State Medical License 2018 - 2025
NY State Medical License 1988 - 2010
American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

Fellow American Heart Association
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Fellow American Association of Neuromuscular and Electrodiagnostic Medicine, 1992

Clinical Trials

A Study to Evaluate the Effects of YM872 on Brain Function and Disability When Administered in Combination With Alteplase (Tissue Plasminogen Activator) Start of enrollment: 2000 Dec 01
Completed
Phase 2
A Study to Evaluate the Effects of YM872 on Stroke Lesion Volume in Acute Stroke Patients Start of enrollment: 2000 Dec 01
Completed
Phase 2
Safety of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke Start of enrollment: 2004 Aug 01
Completed
Phase 2
Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke Start of enrollment: 2003 Jun 01
Completed
Phase 3
Safety and Efficacy of NeuroFlo Technology in Ischemic Stroke (SENTIS) Start of enrollment: 2005 Jun 01
Completed
Phase 3
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke Start of enrollment: 2005 Sep 01
Terminated
Phase 3
Albumin in Acute Ischemic Stroke Trial Start of enrollment: 2006 Jun 01
Terminated
Phase 3
Efficacy of SUN N4057 in Subjects With Acute Ischemic Stroke and Measurable Penumbra on Magnetic Resonance Imaging (MRI) Start of enrollment: 2004 Sep 01
Terminated
Phase 2
ASP-II: Ancrod Stroke Program: Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke Start of enrollment: 2006 Mar 01
Terminated
Phase 3
Effectiveness and Safety Trial of a New Ischemic Stroke Treatment Within 24 Hours From Stroke Onset (NEST-2) Start of enrollment: 2006 Dec 01
Completed
Phase 3
GORE® Septal Occluder Device for Patent Foramen Ovale (PFO) Closure in Stroke Patients Start of enrollment: 2008 Dec 10
Completed
Not Applicable
Efficacy and Safety Study of DP-b99 in Treating Acute Ischemic Stroke Start of enrollment: 2009 Dec 01
Terminated
Phase 3
Efficacy and Safety Trial of Transcranial Laser Therapy Within 24 Hours From Stroke Onset (NEST-3) Start of enrollment: 2010 Sep 01
Completed
Phase 3
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES] Start of enrollment: 2014 Jan 07
Completed
Phase 3
Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS) Start of enrollment: 2014 Nov 27
Completed
Phase 3
Join now to see all

Press Mentions

Mallenbaum Elected Co-Chair of Virginia Stroke System Task ForceSeptember 18th, 2012

Committees

Co-Chair, Virginia Stroke Systems Task Force 2012 - 2015

Professional Memberships